ZYNTEGLO
Live / Registered — Registered — Section 71 accepted (as of 21 Nov 2025)
What this means for you
Registered since 22 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79254523
- Registration number
- 5887775
- Mark type
- Stylized text
- Filed
- 30 Jan 2019
- Published for opposition
- 16 Jul 2019
- Registered
- 22 Oct 2019
- Attorney of record
- Christopher K. Albert
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of genetic diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Genetix Biotherapeutics, Inc., US
- bluebird bio, Inc., Somerville, MA, US
- bluebird bio, Inc., Cambridge, MA, US
- bluebird bio, Inc., Cambridge, MA, US
- bluebird bio (UK) Ltd., GB
Prosecution history
- 18 Dec 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 21 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 21 Nov 2025 — REGISTERED-SEC.71 ACCEPTED
- 17 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 22 Jul 2025 — TEAS SECTION 71 RECEIVED
- 22 Oct 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 13 Sept 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 15 Jun 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Dec 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 26 Aug 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 28 Feb 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 10 Feb 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 10 Feb 2020 — FINAL DISPOSITION PROCESSED
- 22 Jan 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB